Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1080632-76-3 | MDL No. : | MFCD16294429 |
Formula : | C24H25BO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | POKQNZPMVVRGTB-UHFFFAOYSA-N |
M.W : | 356.27 | Pubchem ID : | 58160927 |
Synonyms : |
|
Num. heavy atoms : | 27 |
Num. arom. heavy atoms : | 18 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 113.79 |
TPSA : | 18.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -4.1 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 6.16 |
Log Po/w (WLOGP) : | 5.32 |
Log Po/w (MLOGP) : | 4.1 |
Log Po/w (SILICOS-IT) : | 5.03 |
Consensus Log Po/w : | 4.12 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -6.22 |
Solubility : | 0.000212 mg/ml ; 0.000000596 mol/l |
Class : | Poorly soluble |
Log S (Ali) : | -6.33 |
Solubility : | 0.000166 mg/ml ; 0.000000467 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -8.99 |
Solubility : | 0.000000368 mg/ml ; 0.000000001 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.53 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate In N,N-dimethyl-formamide at 150℃; for 4 h; Inert atmosphere | Compound I-23 (120 g, 388 mmol) in a nitrogen environment, dimethylforamide (DMF) was dissolved in 1.2 L, here bis (pinacolato) diboron (118 g, 466 mmol) and (1,1'-bis (diphenylphosphine) ferrocenedichloropalladium (II) (3.17 g, 3.88 mmol) and into a potassium acetate (114g, 1,164 mmol) was heated to reflux for 4 hours at 150 . After the reaction was completed, the reaction solution into water and then filter the mixture, and dried in a vacuum oven. Thus separated and purified the resulting residue was purified by flash columnchromatography to compound I-24 (124 g, 90percent) was obtained. |
82% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In N,N-dimethyl-formamide at 150℃; for 12 h; Inert atmosphere | Synthesis Example 29: Synthesis of Intermediate I-29 4-bromo-p-terphenyl (50 g, 162 mmol, TCI) was dissolved in dimethylforamide (DMF, 1 L) under a nitrogen environment, bis(pinacolato)diboron (49 g, 194 mmol), (1,1′-bis(diphenylphosphine)ferrocene)dichloropalladium (II) (1.3 g, 1.62 mmol), and potassium acetate (40 g, 405 mmol) were added thereto, and the mixture was heated and refluxed at 150° C. for 12 hours. When the reaction was complete, water was added to the reaction solution, and the mixture was filtered and dried in a vacuum oven. This obtained residue was separated and purified through flash column chromatography to obtain Compound I-29 (47 g and 82percent). HRMS (70 eV, EI+): m/z calcd for C24H25BO2: 356.1948. found: 356. Elemental Analysis: C, 81percent; H, 7percent |
[ 912844-88-3 ]
2-([1,1'-Biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.98
[ 1092390-02-7 ]
4,4,5,5-Tetramethyl-2-(4-(naphthalen-2-yl)phenyl)-1,3,2-dioxaborolane
Similarity: 0.98
[ 651030-56-7 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanol
Similarity: 0.97
[ 651030-55-6 ]
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzeneethanol
Similarity: 0.97
[ 214360-66-4 ]
2-(4-(tert-Butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.95
[ 912844-88-3 ]
2-([1,1'-Biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.98
[ 1092390-02-7 ]
4,4,5,5-Tetramethyl-2-(4-(naphthalen-2-yl)phenyl)-1,3,2-dioxaborolane
Similarity: 0.98
[ 651030-56-7 ]
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanol
Similarity: 0.97
[ 651030-55-6 ]
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzeneethanol
Similarity: 0.97
[ 214360-66-4 ]
2-(4-(tert-Butyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.95